Share This

Public company info - EuroEyes International Eye Clinic Limited , 01846.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

EuroEyes International Eye Clinic Limited, 01846.HK - Company Profile
Chairman Jørn Slot Jørgensen
Share Issued (share) 329,000,000
Par Currency U.S. Dollar
Par Value 0.01
Industry Medical Equipment & Services
Corporate Profile Business Summary: The Group are principally engaged in the provision of vision correction services in Germany, Denmark and the People’s Republic of China (the “PRC”). Performance for the year: For the year ended 31 December 2020, the Group’s gross profit was approximately HK$214.1 million, which represented an increase of approximately HK$36.4 million, or 20.5%, as compared to the year ended 31 December 2019. The gross profit margin for the year ended 31 December 2020 was approximately 45.2%, which represented an increase of 3.8 percentage points as compared to the year ended 31 December 2019. The Group’s net profit after tax for the year ended 31 December 2020 was approximately HK$64.1 million. Business Review: In 2020, the Group confronted challenges head-on, made timely operational optimization and vigorously seized market opportunities, to achieve remarkable results in terms of minimizing the negative impacts of the coronavirus disease 2019 (“COVID-19”) on its businesses, while further strengthening its differentiated competitive strategy in lens surgeries, and significantly improving profitability. As a result, for the year ended 31 December 2020, the total revenue of the Group amounted to approximately HK$473.8 million, which represented an increase of approximately 10.3% as compared to the year ended 31 December 2019. The Group’s gross profit increased from approximately HK$177.7 million for the year ended 31 December 2019 to approximately HK$214.1 million for the year ended 31 December 2020, represented an increase of approximately 20.5% as compared to the year ended 31 December 2019. The Group has vigorously improved its profitability during 2020. The operating profit of the Group for the year ended 31 December 2020 was approximately HK$111.1 million, which represented an increase of approximately 2.7 times as compared to HK$30.4 million for the year ended 31 December 2019. The Group’s net profit after tax increased to approximately HK$64.1 million for the year ended 31 December 2020, which represented an increase of approximately 18.4 times as compared to the net loss after tax of approximately HK$3.7 million for the year ended 31 December 2019. After adjusting for nonrecurring item, the Group’s Adjusted Net Profit After Tax increased to approximately HK$70.6 million for the year ended 31 December 2020, which represented an increase of approximately 40.4% as compared to the year ended 31 December 2019. The Group’s adjusted net profit margin was approximately 14.9% for the year ended 31 December 2020, which represented an increase of 3.2 percentage points compared to 11.7% for the year ended 31 December 2019. Prospects: The Group will focus on the following business strategies: Differentiated Competitive Strategy of Advanced Lens Exchange and ICL Surgery Benefited from the increased awareness of patients towards lens exchange and ICL surgery and growth of penetration rate, the lens exchange and ICL market has a great expansion potential. The Group will reinforce the strategy of taking advanced lens exchange and ICL surgery as the core business and continuing to provide high-quality services to patients, and maintaining a consistent medical satisfaction. Opening of New Clinics The construction of the Group’s clinic in Chongqing has resumed after the local restrictions in response to the COVID-19 outbreak were lifted in the second quarter of 2020, and the clinic in Chongqing will commence operations in April 2021. It is the Group’s seventh clinic in the PRC and brings high-quality vision correction services to the mountain city. The construction of the new flagship clinic in Copenhagen is expected to complete in 2021, in substitution of the Group’s existing clinic. This new clinic is larger in scale. With its prominent location in the center of Copenhagen, it will help meet the increasing demand for the Group’s services in Denmark, which will support the continuous growth of the Group’s business in Denmark. PRC Businesses Operation Outlook The Group’s clinic in Beijing East has achieved breakeven, and its breakeven period was the shortest among the Group’s clinics. It opened in September 2019 and reached breakeven point in June 2020. The successful experience will support the Group to continue to implement the expansion plan of multiple clinics in core metropolitan cities, and one or two new clinics in second-tier cities. Meanwhile, the Group will further improve the profitability of existing clinics through strengthening the Group’s competitive advantages, increasing the lens exchange and ICL operations, as well as effective chain operation management.

Information from the financial statements of listed companies

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.